Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
Marc Miravitlles, Borja G. Cosío, Aurelio Arnedillo Muñoz, et al.
Respiratory Research (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial
Kenneth R. Chapman, John R. Hurst, Stefan Frent, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 198, Iss. 3, pp. 329-339
Closed Access | Times Cited: 216
Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
Carl Randall Harrell, Ruxana T. Sadikot, José L. Pascual, et al.
Stem Cells International (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 177
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
James D. Chalmers, Irena F. Laska, Frits M.E. Franssen, et al.
European Respiratory Journal (2020) Vol. 55, Iss. 6, pp. 2000351-2000351
Open Access | Times Cited: 98
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
Mario Cazzola, Clive P. Page, Jadwiga A. Wedzicha, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
Didier Cataldo, Eric Derom, Giuseppe Liistro, et al.
International Journal of COPD (2018) Vol. Volume 13, pp. 2089-2099
Open Access | Times Cited: 33
<p>Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms</p>
С. Н. Авдеев, З. Р. Айсанов, В. В. Архипов, et al.
International Journal of COPD (2019) Vol. Volume 14, pp. 1267-1280
Open Access | Times Cited: 29
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial
Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, et al.
Respiratory Research (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
H Magnussen, Sarah Lucas, Thérèse Sophie Lapperre, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Chronic Obstructive Pulmonary Disease Exacerbations: A Need for Action
Antonio Anzueto, Marc Miravitlles
The American Journal of Medicine (2018) Vol. 131, Iss. 9, pp. 15-22
Closed Access | Times Cited: 23
Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain
Mónica Monteagudo, Alexa Núñez, Iryna Solntseva, et al.
Archivos de Bronconeumología (2020) Vol. 57, Iss. 3, pp. 205-213
Closed Access | Times Cited: 20
Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators
Antonio Anzueto, Marc Miravitlles
CHEST Journal (2018) Vol. 154, Iss. 2, pp. 242-248
Open Access | Times Cited: 19
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonists the Same?
Marc Miravitlles, Seung Jae Baek, Vatsal Vithlani, et al.
Tuberculosis & respiratory diseases (2018) Vol. 81, Iss. 3, pp. 198-198
Open Access | Times Cited: 15
Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
Se Hee Lee, Ji-Hyun Lee, Ho Il Yoon, et al.
Respiratory Research (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Adherence to GOLD Recommendations among Swiss Pulmonologists and General Practitioners
Joana Marmy, Jens Peter Diedrich, Cordula Cadus, et al.
COPD Journal of Chronic Obstructive Pulmonary Disease (2020) Vol. 18, Iss. 1, pp. 9-15
Open Access | Times Cited: 11
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD
Maria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, et al.
Expert Opinion on Drug Safety (2018) Vol. 17, Iss. 5, pp. 509-517
Closed Access | Times Cited: 8
Placenta‑derived mesenchymal stem cells ameliorate lipopolysaccharide‑induced inflammation in RAW264.7 cells and acute lung injury in rats
Wen Yuan, Hengya Song, Jie Xiong, et al.
Molecular Medicine Reports (2020) Vol. 22, Iss. 2, pp. 1458-1466
Open Access | Times Cited: 8
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Smit Patel, Scott Dickinson, Kevin Morris, et al.
npj Primary Care Respiratory Medicine (2022) Vol. 32, Iss. 1
Open Access | Times Cited: 5
Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease
Eneida Harrison, V. Kim
Respiratory Medicine X (2019) Vol. 1, pp. 100009-100009
Open Access | Times Cited: 7
<p>Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?</p>
Timothy Harries, Gill Gilworth, Christopher J. Corrigan, et al.
International Journal of COPD (2020) Vol. Volume 14, pp. 3063-3066
Open Access | Times Cited: 7
Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
Marie Stolbrink, Laura Bonnett, John Blakey
BMJ Open Respiratory Research (2019) Vol. 6, Iss. 1, pp. e000458-e000458
Open Access | Times Cited: 6
The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease
Kyriakos Souliotis, Luís Silva Miguel, Georgios Hillas, et al.
Therapeutic Advances in Respiratory Disease (2020) Vol. 14, pp. 175346662092680-175346662092680
Open Access | Times Cited: 6
Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease
Amir Hakim, Younis Mohd Khan, Ignacio Esteban, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 199, Iss. 5, pp. 662-664
Open Access | Times Cited: 5
Reducing the use of inhaled corticosteroids in mild-moderate COPD: an observational study in east London
James Cole, Rohini Mathur, Sally Hull
npj Primary Care Respiratory Medicine (2020) Vol. 30, Iss. 1
Open Access | Times Cited: 5
A modified Delphi consensus study to identify improvement proposals for COPD management amongst clinicians and administrators in Spain
Juan Manuel Arriero‐Marín, Domingo Orozco‐Beltrán, Concepción Carratalá‐Munuera, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 5
Closed Access | Times Cited: 5
<p>A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management</p>
Claudio Micheletto, Fulvio Braido, Marco Contoli, et al.
International Journal of COPD (2019) Vol. Volume 14, pp. 2185-2193
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top